VEGFR Targeted Therapies and Combinations Emerge for the Treatment of Sarcomas
July 2nd 2019Based on the ongoing and positive data observed with VEGFR targeted therapies, novel tyrosine kinase inhibitors and those already approved for other disease indications may become available to patients with bone and soft tissue sarcomas.